1-3 of 3
Mary A. Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Yasmin Abaza, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Deborah A Thomas, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Jan Burger, MD PhD, William G. Wierda, MD PhD, Nitin Jain, MD, Stefan Faderl, MD, Susan M. O'Brien, MD, Marina Konopleva, MD PhD, Alessandra Ferrajoli, MD, Steven M Kornblau, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Mary A. Kelly, Rebecca Garris, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2016) 128 (22): 177.
https://doi.org/10.1182/blood.V128.22.177.177
Published: 2016
Journal Articles

Mobilization and Elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) Stem/Progenitor Cells by Plerixafor/G-CSF/Sorafenib: Results From a Phase I Trial in Relapsed/Refractory AML Patients

Michael Andreeff, MD, PhD, Zhihong Zeng, PhD, Mary A Kelly, RN, Rui-yu Wang, MD, PhD, Teresa McQueen, BS, Seshagiri Duvvuri, Gul Nowshad, Gautam Borthakur, MD, Jan A. Burger, MD, PhD, Tapan M. Kadia, M.D., Elias Jabbour, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Marina Konopleva, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 142.
https://doi.org/10.1182/blood.V120.21.142.142
Published: 2012
Journal Articles

Phase II Study of the Histone Deacetylase Inhibitor Panabinostat (LBH589) in Patients with Low or Intermediate-1 Risk Myelodysplastic syndrome

Sophie Dimicoli, MD, PhD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Zeev Estrov, Hui Yang, MD, PhD, Mary A Kelly, RN, Sherry Pierce, RN, BS, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2011) 118 (21): 1731.
https://doi.org/10.1182/blood.V118.21.1731.1731
Published: 2011